Cite
Penkert RR, Chandramouli S, Dormitzer PR, et al. Novel Surrogate Neutralizing Assay Supports Parvovirus B19 Vaccine Development for Children with Sickle Cell Disease. Vaccines (Basel). 2021;9(8)doi: 10.3390/vaccines9080860.
Penkert, R. R., Chandramouli, S., Dormitzer, P. R., Settembre, E. C., Sealy, R. E., Wong, S., Young, N. S., Sun, Y., Tang, L., Cotton, A., Dowdy, J., Hayden, R. T., Hankins, J. S., & Hurwitz, J. L. (2021). Novel Surrogate Neutralizing Assay Supports Parvovirus B19 Vaccine Development for Children with Sickle Cell Disease. Vaccines, 9(8), . https://doi.org/10.3390/vaccines9080860
Penkert, Rhiannon R, et al. "Novel Surrogate Neutralizing Assay Supports Parvovirus B19 Vaccine Development for Children with Sickle Cell Disease." Vaccines vol. 9,8 (2021). doi: https://doi.org/10.3390/vaccines9080860
Penkert RR, Chandramouli S, Dormitzer PR, Settembre EC, Sealy RE, Wong S, Young NS, Sun Y, Tang L, Cotton A, Dowdy J, Hayden RT, Hankins JS, Hurwitz JL. Novel Surrogate Neutralizing Assay Supports Parvovirus B19 Vaccine Development for Children with Sickle Cell Disease. Vaccines (Basel). 2021 Aug 04;9(8). doi: 10.3390/vaccines9080860. PMID: 34451986; PMCID: PMC8402426.
Copy
Download .nbib
